Pharma: Other News To Note
Wednesday, April 25, 2012
• Shengtai Pharmaceutical Inc., of Weifang, China, said a special committee of its board will consider a preliminary, nonbinding proposal from its chairman and CEO, Qingtai Liu, to acquire all outstanding shares of the company's common stock in a going private transaction.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.